This Week in Radiology — Oct 31, 2026
Generated Oct 31, 2026 · 9:51
The week's practice-changing Radiology research, summarized for clinicians.
If the audio fails to play, refresh the page to renew the link.
Get next week’s Radiology briefing — free.
In your podcast app, or readable in your inbox with the audio one tap away.
Mechanical Thrombectomy 24 to 72 Hours after Large-Vessel Ischemic Stroke.
Thrombectomy 24 to 72 hours after anterior large-vessel stroke with salvageable tissue improved 90-day function but raised symptomatic hemorrhage and mortality compared with medical care alone.
New England Journal of Medicine · 2026 · PubMed
This week’s papers
- 01
Mechanical Thrombectomy 24 to 72 Hours after Large-Vessel Ischemic Stroke.
Thrombectomy 24 to 72 hours after anterior large-vessel stroke with salvageable tissue improved 90-day function but raised symptomatic hemorrhage and mortality compared with medical care alone.
Yang P et al. · New England Journal of Medicine · 2026
From the briefingIn LATE-MT, Yang and colleagues randomized 336 patients with anterior circulation large-vessel occlusion who arrived 24 to 72 hours after onset but still had imaging-identified salvageable tissue [1]. The median time to randomization was about 38 hours, well beyond anything in prior trials. Thrombectomy produced a better spread of disability scores at 90 days, with roughly three quarters higher odds of a better functional outcome. That benefit came at a real cost: symptomatic hemorrhage occurred in just under five percent of treated patients and in none of the controls, and 90-day mortality was about six percent with thrombectomy versus under two percent with medical care. So the trial supports a functional benefit in this very late window, but the trade-off is explicit, it is a single open-label trial, and the selection rests entirely on the imaging criteria used.
If you only have time for one paper this week, make it LATE-MT in the New England Journal of Medicine [1]. It reopens the question of whether time from onset should limit thrombectomy at all when imaging shows salvageable tissue, while putting hard numbers on the hemorrhage and mortality price, which places imaging selection squarely at the centre of the decision.
Written by AI from the published abstract, for healthcare professionals. Not medical advice; check the paper before acting on it.
- 02
Trial of Endovascular Therapy for Mild Stroke with Large-Vessel Occlusion.
In mild large-vessel stroke with large perfusion mismatch, thrombectomy raised excellent 90-day outcomes from 50 to about 69 percent, without more hemorrhage but with frequent serious procedural complications.
Liu J et al. · New England Journal of Medicine · 2026
From the briefingIn the companion trial, MILD-MT, Liu and colleagues randomized 300 patients with mild deficits, a stroke scale score under six, but a small core and a large perfusion mismatch within 24 hours [2]. Excellent outcome, meaning essentially no disability, was reached by about 69 percent of the thrombectomy group versus half of the medical group, roughly a twenty-point gain, with no increase in symptomatic hemorrhage. The caution here is that serious procedure-related complications occurred in about one in eight treated patients. For a population that often does well without intervention, that complication rate matters, and the result comes from a single trial in China.
Written by AI from the published abstract, for healthcare professionals. Not medical advice; check the paper before acting on it.
- 03
Intended Thrombectomy for Basilar Artery Occlusion with Mild Deficits: Evidence from a Multicenter Prospective Registry.
In basilar occlusion with mild deficits, registry data linked thrombectomy to better function and lower mortality, but functional benefit appeared only with stroke scale scores of six to nine.
Qiu K et al. · Radiology · 2026
From the briefingIn Radiology, Qiu and colleagues report a prospective eight-centre registry of 401 patients with basilar artery occlusion and mild deficits, a stroke scale score under ten [3]. After weighting for baseline differences, intended thrombectomy was associated with about fifty percent higher odds of functional independence, along with lower odds of death and of early neurologic deterioration. But the functional benefit appeared only in patients scoring six to nine, not in those scoring zero to five, although even the mildest patients had less deterioration and death. Sensitivity analyses accounting for patients who crossed over to rescue thrombectomy weakened the advantage. Read alongside MILD-MT, this suggests that how mild is mild may differ by vascular territory, and that the very mildest basilar patients remain a genuinely open question awaiting randomized data.
Written by AI from the published abstract, for healthcare professionals. Not medical advice; check the paper before acting on it.
- 04
Endovascular Thrombectomy for Large Vessel Occlusion Stroke in Patients with Metastatic Cancer.
Among large-vessel stroke patients with metastatic cancer, thrombectomy roughly doubled functional independence at discharge in national retrospective data, without changing in-hospital or 180-day mortality.
Chen H et al. · American Journal of Neuroradiology · 2026
From the briefingRounding out the theme, Chen and colleagues in the American Journal of Neuroradiology used a national readmissions database to match about 3,600 stroke patients with metastatic cancer [4]. Thrombectomy roughly doubled the rate of functional independence at discharge, though that still reached fewer than one in five patients, and it improved discharge home, while in-hospital and 180-day mortality were unchanged. This is retrospective administrative data with discharge-level outcomes only, but it argues against treating metastatic cancer as an automatic exclusion, since the gain appears to be in function rather than survival.
Written by AI from the published abstract, for healthcare professionals. Not medical advice; check the paper before acting on it.
- 05
Management of Chronic Subdural Hematoma in Thrombocytopenia: Middle Meningeal Artery Embolization - Based Strategies Versus Medical Management or Surgery Alone.
In thrombocytopenic chronic subdural hematoma, strategies including middle meningeal artery embolization were associated with lower 90-day mortality, though not significantly so when platelets were below 50 thousand.
Dhaduk V et al. · American Journal of Neuroradiology · 2026
From the briefingStaying in neurointervention, Dhaduk and colleagues, also in the American Journal of Neuroradiology, tackle chronic subdural hematoma in patients with low platelet counts, a group where surgery is fraught [5]. Using a large federated health record network and propensity matching, strategies including middle meningeal artery embolization were associated with about ten points lower 90-day mortality, both as a standalone approach compared with medical management and when added to surgery. In severe thrombocytopenia, below 50 thousand, the mortality difference pointed the same way but did not reach statistical significance, and rates of later surgical evacuation did not differ in any comparison. The authors are clear that prospective confirmation is needed; this is hypothesis-generating observational evidence in a population no trial has addressed.
Written by AI from the published abstract, for healthcare professionals. Not medical advice; check the paper before acting on it.
- 06
Automated Opportunistic Bone Mineral Density Assessment at Low-Dose CT Lung Cancer Screening: Incident Vertebral Fractures and Mortality.
Automated spinal bone density from lung screening CT predicted vertebral fractures, with osteoporotic values carrying a two-year fracture incidence near six percent, above guideline treatment thresholds.
Löffler MT et al. · Radiology · 2026
From the briefingOur second theme is extracting more value from imaging already being performed. In Radiology, Löffler and colleagues applied fully automated spinal bone density software to low-dose CT scans from the National Lung Screening Trial, covering nearly 22 thousand heavy smokers [6]. Compared with normal bone density, osteoporotic values more than tripled the risk of a new vertebral fracture within two years, and low bone mass roughly doubled it. The two-year fracture incidence in the osteoporotic group was about six percent, which sits above the five percent treatment threshold in current osteoporosis guidelines. Osteoporotic density was also associated with about a quarter higher mortality in men after adjustment. This is a secondary analysis of trial data collected two decades ago, but it strengthens the case that screening CT can flag fracture risk at no added radiation dose, with the open question being how such results would be acted on in practice.
Written by AI from the published abstract, for healthcare professionals. Not medical advice; check the paper before acting on it.
- 07
ESR Essentials: trauma whole-body CT imaging-practice recommendations by the European Society of Emergency Radiology.
European emergency radiologists recommend whole-body trauma CT protocols tailored to physiology and mechanism, radiologists embedded in trauma teams, and checklist-driven structured reporting with defined communication pathways.
Limaye N et al. · European Radiology · 2026
From the briefingIn European Radiology, the European Society of Emergency Radiology, writing with Limaye and colleagues, sets out three recommendations for whole-body trauma CT [7]: protocols tailored to haemodynamic status and injury mechanism, choosing among split-bolus, dual-phase and triple-phase techniques rather than a single universal protocol; radiologists embedded actively in the trauma team, directing attention to life-threatening injuries in real time; and checklist-driven structured reporting with defined communication pathways.
Written by AI from the published abstract, for healthcare professionals. Not medical advice; check the paper before acting on it.
- 08
ESR Essentials: "Gadolinium-free" pediatric neuroimaging-practice recommendations by the European Society of Neuroradiology.
Expert European neuroradiologists argue that many routine pediatric gadolinium uses lack strong evidence and should be justified case by case, given concerns about brain gadolinium retention.
Righini A et al. · European Radiology · 2026
From the briefingAlso in European Radiology, the European Society of Neuroradiology, with Righini and colleagues, revisits gadolinium use in pediatric neuroimaging [8]. Citing evidence of brain retention after repeated doses, the panel argues that several common indications rest on longstanding habit rather than strict evidence and that contrast should be justified case by case. The authors explicitly frame this as expert opinion and call for better unenhanced sequences. In the Journal of the American College of Radiology, two Appropriateness Criteria updates arrived.
Written by AI from the published abstract, for healthcare professionals. Not medical advice; check the paper before acting on it.
- 09
ACR Appropriateness Criteria® Pretreatment Evaluation and Follow-Up of Endometrial Cancer: 2026 Update.
Updated ACR criteria favour contrast pelvic MRI for local endometrial cancer staging and rate routine surveillance imaging usually not appropriate for asymptomatic treated low- or intermediate-risk disease.
Sertic M et al. · Journal of the American College of Radiology · 2026
From the briefingFor endometrial cancer, Sertic and colleagues rate contrast-enhanced pelvic MRI as usually appropriate for local staging across subtypes, CT and FDG PET-CT for aggressive histologies or suspected metastases, and routine surveillance imaging as usually not appropriate for asymptomatic treated low- or intermediate-risk disease, with CT possibly appropriate in selected high-risk patients [9].
Written by AI from the published abstract, for healthcare professionals. Not medical advice; check the paper before acting on it.
- 10
ACR Appropriateness Criteria® Staging and Follow-Up of Biliary Cancer.
ACR criteria keep contrast-enhanced abdominal CT and MRI as mainstays for locoregional biliary cancer staging, with body CT and FDG PET used for distant staging and follow-up.
Kamal O et al. · Journal of the American College of Radiology · 2026
From the briefingFor biliary cancers, Kamal and colleagues keep contrast-enhanced CT and MRI as the mainstays of locoregional staging, with chest, abdomen and pelvis CT and FDG PET used for distant staging and follow-up [10]. Both documents note that where literature is thin, expert judgement fills the gap.
Written by AI from the published abstract, for healthcare professionals. Not medical advice; check the paper before acting on it.
The full briefing
This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice.
Welcome to This Week in Radiology. This week we're covering 10 notable papers spanning the expanding boundaries of thrombectomy and neurointervention, opportunistic value from screening CT, and a cluster of new practice guidance on trauma, contrast use, and oncologic imaging. Let's dive in.
The biggest story this week is how far imaging-selected thrombectomy can be stretched, in time, in severity, and in patient complexity. Two Chinese randomized trials in the New England Journal of Medicine push in different directions. In LATE-MT, Yang and colleagues randomized 336 patients with anterior circulation large-vessel occlusion who arrived 24 to 72 hours after onset but still had imaging-identified salvageable tissue [1]. The median time to randomization was about 38 hours, well beyond anything in prior trials. Thrombectomy produced a better spread of disability scores at 90 days, with roughly three quarters higher odds of a better functional outcome. That benefit came at a real cost: symptomatic hemorrhage occurred in just under five percent of treated patients and in none of the controls, and 90-day mortality was about six percent with thrombectomy versus under two percent with medical care. So the trial supports a functional benefit in this very late window, but the trade-off is explicit, it is a single open-label trial, and the selection rests entirely on the imaging criteria used. In the companion trial, MILD-MT, Liu and colleagues randomized 300 patients with mild deficits, a stroke scale score under six, but a small core and a large perfusion mismatch within 24 hours [2]. Excellent outcome, meaning essentially no disability, was reached by about 69 percent of the thrombectomy group versus half of the medical group, roughly a twenty-point gain, with no increase in symptomatic hemorrhage. The caution here is that serious procedure-related complications occurred in about one in eight treated patients. For a population that often does well without intervention, that complication rate matters, and the result comes from a single trial in China.
The posterior circulation adds nuance. In Radiology, Qiu and colleagues report a prospective eight-centre registry of 401 patients with basilar artery occlusion and mild deficits, a stroke scale score under ten [3]. After weighting for baseline differences, intended thrombectomy was associated with about fifty percent higher odds of functional independence, along with lower odds of death and of early neurologic deterioration. But the functional benefit appeared only in patients scoring six to nine, not in those scoring zero to five, although even the mildest patients had less deterioration and death. Sensitivity analyses accounting for patients who crossed over to rescue thrombectomy weakened the advantage. Read alongside MILD-MT, this suggests that how mild is mild may differ by vascular territory, and that the very mildest basilar patients remain a genuinely open question awaiting randomized data. Rounding out the theme, Chen and colleagues in the American Journal of Neuroradiology used a national readmissions database to match about 3,600 stroke patients with metastatic cancer [4]. Thrombectomy roughly doubled the rate of functional independence at discharge, though that still reached fewer than one in five patients, and it improved discharge home, while in-hospital and 180-day mortality were unchanged. This is retrospective administrative data with discharge-level outcomes only, but it argues against treating metastatic cancer as an automatic exclusion, since the gain appears to be in function rather than survival.
Staying in neurointervention, Dhaduk and colleagues, also in the American Journal of Neuroradiology, tackle chronic subdural hematoma in patients with low platelet counts, a group where surgery is fraught [5]. Using a large federated health record network and propensity matching, strategies including middle meningeal artery embolization were associated with about ten points lower 90-day mortality, both as a standalone approach compared with medical management and when added to surgery. In severe thrombocytopenia, below 50 thousand, the mortality difference pointed the same way but did not reach statistical significance, and rates of later surgical evacuation did not differ in any comparison. The authors are clear that prospective confirmation is needed; this is hypothesis-generating observational evidence in a population no trial has addressed.
Our second theme is extracting more value from imaging already being performed. In Radiology, Löffler and colleagues applied fully automated spinal bone density software to low-dose CT scans from the National Lung Screening Trial, covering nearly 22 thousand heavy smokers [6]. Compared with normal bone density, osteoporotic values more than tripled the risk of a new vertebral fracture within two years, and low bone mass roughly doubled it. The two-year fracture incidence in the osteoporotic group was about six percent, which sits above the five percent treatment threshold in current osteoporosis guidelines. Osteoporotic density was also associated with about a quarter higher mortality in men after adjustment. This is a secondary analysis of trial data collected two decades ago, but it strengthens the case that screening CT can flag fracture risk at no added radiation dose, with the open question being how such results would be acted on in practice.
The final theme is practice guidance, where several societies have issued recommendations largely built on expert consensus. In European Radiology, the European Society of Emergency Radiology, writing with Limaye and colleagues, sets out three recommendations for whole-body trauma CT [7]: protocols tailored to haemodynamic status and injury mechanism, choosing among split-bolus, dual-phase and triple-phase techniques rather than a single universal protocol; radiologists embedded actively in the trauma team, directing attention to life-threatening injuries in real time; and checklist-driven structured reporting with defined communication pathways. Also in European Radiology, the European Society of Neuroradiology, with Righini and colleagues, revisits gadolinium use in pediatric neuroimaging [8]. Citing evidence of brain retention after repeated doses, the panel argues that several common indications rest on longstanding habit rather than strict evidence and that contrast should be justified case by case. The authors explicitly frame this as expert opinion and call for better unenhanced sequences. In the Journal of the American College of Radiology, two Appropriateness Criteria updates arrived. For endometrial cancer, Sertic and colleagues rate contrast-enhanced pelvic MRI as usually appropriate for local staging across subtypes, CT and FDG PET-CT for aggressive histologies or suspected metastases, and routine surveillance imaging as usually not appropriate for asymptomatic treated low- or intermediate-risk disease, with CT possibly appropriate in selected high-risk patients [9]. For biliary cancers, Kamal and colleagues keep contrast-enhanced CT and MRI as the mainstays of locoregional staging, with chest, abdomen and pelvis CT and FDG PET used for distant staging and follow-up [10]. Both documents note that where literature is thin, expert judgement fills the gap.
If you only have time for one paper this week, make it LATE-MT in the New England Journal of Medicine [1]. It reopens the question of whether time from onset should limit thrombectomy at all when imaging shows salvageable tissue, while putting hard numbers on the hemorrhage and mortality price, which places imaging selection squarely at the centre of the decision.
Here is what this week's evidence adds up to in Radiology. First, randomized data now suggest functional benefit from thrombectomy both beyond 24 hours and in mild anterior circulation strokes with large mismatch, but each rests on a single Chinese trial and each carries a clear safety cost, higher hemorrhage and death late, and frequent procedural complications in mild stroke. Second, for mild basilar occlusion, registry data suggest benefit is confined to moderately mild deficits, and the mildest patients remain unsettled. Third, observational data in metastatic cancer and in thrombocytopenic subdural hematoma point toward benefit from endovascular strategies, but neither is randomized and both need prospective confirmation. Fourth, automated bone density from lung screening CT identifies a group whose fracture risk exceeds guideline treatment thresholds, though how to operationalize that remains open. And finally, new society guidance on trauma CT, pediatric gadolinium, and endometrial and biliary cancer imaging largely codifies expert consensus rather than new trial evidence.
That's your roundup for This Week in Radiology. The full transcript and references are available on the episode page. This is an AI-curated summary — for clinical decisions, always consult primary sources and current guidelines. See you next week.
If this weekly briefing is useful, follow the show in your podcast app so new episodes arrive automatically. And if it saves you time, a quick rating in your podcast app helps other physicians find the show.
This is an automated summary generated by artificial intelligence, which can make mistakes. Always review the original source materials.
Spot something worth flagging?
Get this every week in your podcast app — free.
New radiology episodes land in your feed automatically — listen on your commute.